Lars Hillringhaus
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
- Protein purification and stability 2
- Co-authors
- Nathan R. Rose (3 shared papers)Christopher John Schofield (3 shared papers)Esther C. Y. Woon (2 shared papers)M.A. McDonough (2 shared papers)Akane Kawamura (2 shared papers)Oliver N. F. King (1 shared paper)Rasheduzzaman Chowdhury (1 shared paper)Kar Kheng Yeoh (1 shared paper)
- Journals
- Clinical Biochemistry (1 paper)Frontiers in Immunology (1 paper)Scientific Reports (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Lars Hillringhaus
12 papers receiving 1.2k citations
Lars Hillringhaus's Hit Papers
Peers
Comparison fields: 5 of 66
- Genetics 234
- Cancer Research 310
- Hematology 115
- Molecular Biology 530
- Biochemistry 37
Countries citing papers authored by Lars Hillringhaus
This map shows the geographic impact of Lars Hillringhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hillringhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hillringhaus more than expected).
Fields of papers citing papers by Lars Hillringhaus
This network shows the impact of papers produced by Lars Hillringhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hillringhaus. The network helps show where Lars Hillringhaus may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Hillringhaus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases Hit paper breakdown → | 2011 | 864 |
| 2 | 2011 | 157 | |
| 3 | 2019 | 80 | |
| 4 | 2012 | 70 | |
| 5 | 2005 | 27 | |
| 6 | 2007 | 23 | |
| 7 | 2019 | 22 | |
| 8 | 2016 | 17 | |
| 9 | 2023 | 12 | |
| 10 | 2024 | 3 | |
| 11 | 2018 | 1 | |
| 12 | 2024 | 1 |
About Lars Hillringhaus
Lars Hillringhaus is a scholar working on Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging, Physiology and Genetics, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Clinical Laboratory Practices and Quality Control (2 papers), Alzheimer's disease research and treatments (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Cancer-related gene regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Protein purification and stability (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Genetics (234 citations), Cancer Research (310 citations), Hematology (115 citations), Molecular Biology (530 citations) and Biochemistry (37 citations). Lars Hillringhaus has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Nathan R. Rose, Christopher John Schofield, Esther C. Y. Woon, M.A. McDonough, Akane Kawamura, Oliver N. F. King, Rasheduzzaman Chowdhury, Kar Kheng Yeoh, Timothy D. W. Claridge and Robert J. Klose. Their work appears in journals such as Clinical Biochemistry, Frontiers in Immunology, Scientific Reports, European Journal of Pharmaceutics and Biopharmaceutics and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.